Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
<p>Abstract</p> <p>Background</p> <p>17alpha-hydroxyprogesterone caproate (17P) administration reportedly improves outcome for women with a previous spontaneous preterm delivery. This study, using in vitro strips of human uterine smooth muscle, aimed to investigate the...
Saved in:
Main Authors: | Morrison John J (Author), Friel Anne M (Author), O'Reilly Michael W (Author), Sexton Donal J (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2004-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
by: Carla E. Ransom, et al.
Published: (2011) -
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
by: Stephanie M. Garcia, et al.
Published: (2021) -
Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
by: Robert Egerman, et al.
Published: (2014) -
Effect of 17 α-Hydroxyprogesterone Caproate on the Prevention of Preterm Labor: A Randomized Controlled Trial Study
by: Hamed Jafarpour, et al.
Published: (2020) -
17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB Activation
by: Tao Hu, et al.
Published: (2022)